Skip to content

Evaluating the impact of two doses of Labetalol on pre-induction quality in adult patients.

A Randomised and Comparative study of attenuation of hemodynamic responses to Laryngoscopy and Endotracheal Intubation during pre-induction with two different Intravenous doses of Labetalol. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078060
Enrollment
60
Registered
2024-12-12
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Intravenous injection of Labetalol 0.1 mg/kg: Intravenous injection of Labetalol 0.1 mg/kg over 10 minutes just before laryngoscopy and endotracheal intubation. At 1 min At 3 min At 5 m

Sponsors

Smt.Bhikiben Kanjibhai Shah Medical Institute and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to sign written and informed consent. Male or Female patients between 18 to 65 years of age. Patients belonging to American Society of Anaesthesiologists(ASA) physical status I,II. Patients posted for elective surgeries under general anaesthesia.

Exclusion criteria

Exclusion criteria: Patients unwilling to participate in study. Patients with Body Mass Index more than 30 mg/m2. Patients with cardiovascular, cerebrovascular, hepatic and renal diseases. Bradycardia, HR less than 70/min. Arrhythmias. Psychiatric patients. Pregnancy and lactating women. Patients belonging to the American Society of Anaesthesiologists (ASA) III and above. Patients taking any type of medication for hypertension. Patients allergic to the study drugs. Patients with anticipated difficult airways. Patients with neuromuscular diseases.

Design outcomes

Primary

MeasureTime frame
To study hemodynamic and respiratory responses during endotracheal and laryngeal intubation.Timepoint: Preoperative After test drug administration During laryngoscopy and endotracheal intubation At 1 min At 3 min At 5 min At 7 min At 10 min

Secondary

MeasureTime frame
To study any intra operative complications like bradycardia, hypotension, arrhythmias.Timepoint: Hemodynamic parameters will be recorded every 2 minutes for 10 minutes after intubation. At 1 min At 3 min At 5 min At 7 min At 10 min

Countries

India

Contacts

Public ContactDr Dinesh Chauhan

Smt.Bhikiben Kanjibhai Shah Medical Institute and Research Centre

drdinesh77@gmail.com9099014672

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026